Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

If there’s one thing orthopedic surgeons appreciate, it’s strong bones, solid structure — and a well-funded fellowship.

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Product Performance – potency and dosing: Cryogenic transmission electron microscopy (Cryo-TEM) revealed more uniform, solid-core particles. Increased lipid and RNA concentrations can enhance in vivo ...

Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

Viruses occupy a central place in ecology and health, influencing the dynamics of terrestrial, aquatic, and managed ...